51 results
424B5
ARAV
Aravive Inc
31 Mar 22
Prospectus supplement for primary offering
6:06am
delays in patient enrollment and deems it necessary or advisable to improve patient recruitment by, among other things, opening additional clinical … -19 on patient recruitment in clinical trials and considering patient safety and trial integrity, we have decided to amend our ccRCC trial to initiate
424B3
5fuc1qefne nlkv
19 Jan 22
Prospectus supplement
4:05pm
424B5
t2wqwgqpc7pyzwa osh6
16 Feb 21
Prospectus supplement for primary offering
7:05am
8-K
EX-99.2
kg2t9767
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
424B3
ov7k4ylj8nesmbw6
14 Jul 20
Prospectus supplement
4:05pm